Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1955 1
1956 1
1957 1
1960 1
1963 1
1969 1
1971 1
1973 1
1974 1
1976 1
1978 1
1980 2
1982 1
1984 3
1985 6
1986 3
1987 1
1988 3
1989 4
1990 4
1991 6
1992 5
1993 3
1994 8
1995 13
1996 11
1997 9
1998 13
1999 15
2000 21
2001 18
2002 27
2003 30
2004 29
2005 36
2006 35
2007 40
2008 62
2009 76
2010 82
2011 77
2012 100
2013 92
2014 98
2015 94
2016 85
2017 86
2018 98
2019 101
2020 119
2021 125
2022 113
2023 107
2024 117
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,750 results

Results by year

Filters applied: . Clear all
Page 1
Clinical proteomics.
Celis JE, Moreira JM. Celis JE, et al. Among authors: moreira jm. Mol Cell Proteomics. 2008 Oct;7(10):1779. doi: 10.1074/mcp.E800010-MCP200. Mol Cell Proteomics. 2008. PMID: 18843147 Free article. No abstract available.
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.
Melody M, Epperla N, Shouse G, Romancik J, Allen P, Moyo TK, Kenkre V, Ollila T, Fitzgerald L, Hess B, David K, Herr MM, Odetola O, Lin A, Moreira J, Ma S, Winter JN, Roy I, Stephens D, Danilov A, Shah NN, Barta SK, Cortese M, Cohen JB, Gordon LI, Karmali R. Melody M, et al. Among authors: moreira j. Blood Adv. 2024 May 28;8(10):2327-2331. doi: 10.1182/bloodadvances.2024012573. Blood Adv. 2024. PMID: 38498727 Free PMC article. No abstract available.
Cannabinoid type 2 receptor inhibition enhances the antidepressant and proneurogenic effects of physical exercise after chronic stress.
Rodrigues RS, Moreira JB, Mateus JM, Barateiro A, Paulo SL, Vaz SH, Lourenço DM, Ribeiro FF, Soares R, Loureiro-Campos E, Bielefeld P, Sebastião AM, Fernandes A, Pinto L, Fitzsimons CP, Xapelli S. Rodrigues RS, et al. Among authors: moreira jb. Transl Psychiatry. 2024 Mar 30;14(1):170. doi: 10.1038/s41398-024-02877-0. Transl Psychiatry. 2024. PMID: 38555299 Free PMC article.
A tomato B-box protein regulates plant development and fruit quality through the interaction with PIF4, HY5, and RIN transcription factors.
Shiose L, Moreira JDR, Lira BS, Ponciano G, Gómez-Ocampo G, Wu RTA, Dos Santos Júnior JL, Ntelkis N, Clicque E, Oliveira MJ, Lubini G, Floh EIS, Botto JF, Ferreira MJP, Goossens A, Freschi L, Rossi M. Shiose L, et al. Among authors: moreira jdr. J Exp Bot. 2024 Jun 7;75(11):3368-3387. doi: 10.1093/jxb/erae119. J Exp Bot. 2024. PMID: 38492237
Adventures in targeting.
Allen TM, Sapra P, Moase E, Moreira J, Iden D. Allen TM, et al. Among authors: moreira j. J Liposome Res. 2002 Feb-May;12(1-2):5-12. doi: 10.1081/lpr-120004771. J Liposome Res. 2002. PMID: 12604033
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy.
Karmali R, Machhi R, Epperla N, Shouse G, Romancik J, Moyo TK, Kenkre V, Ollila TA, Fitzgerald L, Hess B, David K, Roy I, Zurko J, Chowdhury SM, Annunzio K, Ferdman R, Bhansali RS, Harris EI, Liu J, Nizamuddin I, Ma S, Moreira J, Winter J, Pro B, Stephens DM, Danilov A, Shah NN, Cohen JB, Barta SK, Torka P, Gordon LI. Karmali R, et al. Among authors: moreira j. Blood Adv. 2024 May 28;8(10):2592-2599. doi: 10.1182/bloodadvances.2023011996. Blood Adv. 2024. PMID: 38531057 Free PMC article.
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil.
Nogueira ML, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, de Oliveira Alves LB, Infante V, Silveira DHR, de Lacerda MVG, Pereira DB, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Boaventura VS, Ramos F, Júnior EE, de Moraes JC, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Kallás EG; Phase 3 Butantan-DV Working Group. Nogueira ML, et al. Among authors: moreira ja. Lancet Infect Dis. 2024 Nov;24(11):1234-1244. doi: 10.1016/S1473-3099(24)00376-1. Epub 2024 Aug 5. Lancet Infect Dis. 2024. PMID: 39116904 Clinical Trial.
1,750 results